Literature DB >> 20364296

Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties.

Ana Nunes1, Maria Podinovskaia, Andreia Leite, Paula Gameiro, Tao Zhou, Yongmin Ma, Xiaole Kong, Ulrich E Schaible, Robert C Hider, Maria Rangel.   

Abstract

We report the synthesis and characterization of a fluorescent iron chelator (4), shown to be effective in inhibiting the growth of Mycobacterium avium in macrophages, together with the synthesis and characterization of two unsuccessful analogues selected to facilitate identification of the molecular properties responsible for the antimicrobial activity. Partition of the chelators in liposomes was investigated and the compounds were assessed with respect to uptake by macrophages, responsiveness to iron overload/iron deprivation and intracellular distribution by flow cytometry and confocal microscopy. The synthesis of the hexadentate chelators is based on a tetrahedral structure to which three bidentate 3-hydroxy-4-pyridinone chelating units are linked via amide bonds. The structure is synthetically versatile, allowing further addition of functional groups such as fluorophores. Here, we analyse the non-functionalized hexadentate unit (3) and the corresponding rhodamine B (4) and fluorescein (5) labelled chelators. The iron(III) stability constant was determined for 3 and the values log beta = 34.4 and pFe(3+) = 29.8 indicate an affinity for iron of the same order of magnitude as that of mycobacteria siderophores. Fluorescence properties in the presence of liposomes show that 4 strongly interacts with the lipid phase, whereas 5 does not. Such different behaviour may explain their distinct intracellular localization as revealed by confocal microscopy. The flow cytometry and confocal microscopy studies indicate that 4 is readily engulfed by macrophages and targeted to cytosol and vesicles of the endolysosomal continuum, whereas 5 is differentially distributed and only partially colocalizes with 4 after prolonged incubation. Differential distribution of the compounds is likely to account for their different efficacy against mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20364296     DOI: 10.1007/s00775-010-0650-1

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  32 in total

1.  Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators.

Authors:  Zu D Liu; Reem Kayyali; Robert C Hider; John B Porter; Anthony E Theobald
Journal:  J Med Chem       Date:  2002-01-31       Impact factor: 7.446

2.  Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase.

Authors:  T D Rae; P J Schmidt; R A Pufahl; V C Culotta; T V O'Halloran
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

Review 3.  Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods.

Authors:  Nuno C Santos; Manuel Prieto; Miguel A R B Castanho
Journal:  Biochim Biophys Acta       Date:  2003-06-10

4.  Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.

Authors:  Hava Glickstein; Rinat Ben El; Maya Shvartsman; Z Ioav Cabantchik
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

Review 5.  Iron and infection: competition between host and microbes for a precious element.

Authors:  J J M Marx
Journal:  Best Pract Res Clin Haematol       Date:  2002-06       Impact factor: 3.020

6.  Mycobactin-mediated iron acquisition within macrophages.

Authors:  Minkui Luo; Evgeny A Fadeev; John T Groves
Journal:  Nat Chem Biol       Date:  2005-07-03       Impact factor: 15.040

7.  Iron chelation properties of an extracellular siderophore exochelin MS.

Authors:  Suraj Dhungana; Colin Ratledge; Alvin L Crumbliss
Journal:  Inorg Chem       Date:  2004-10-04       Impact factor: 5.165

8.  Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin.

Authors:  Robert Bucki; Jennifer J Pastore; Paramjeet Randhawa; Rolands Vegners; Daniel J Weiner; Paul A Janmey
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium.

Authors:  Sofia Sousa Fernandes; Ana Nunes; Ana Rita Gomes; Baltazar de Castro; Robert C Hider; Maria Rangel; Rui Appelberg; Maria Salomé Gomes
Journal:  Microbes Infect       Date:  2010-01-25       Impact factor: 2.700

10.  New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation.

Authors:  Raquel Grazina; Lurdes Gano; Jaroslav Sebestík; M Amelia Santos
Journal:  J Inorg Biochem       Date:  2008-10-30       Impact factor: 4.155

View more
  7 in total

1.  A novel antimycobacterial compound acts as an intracellular iron chelator.

Authors:  Marte S Dragset; Giovanna Poce; Salvatore Alfonso; Teresita Padilla-Benavides; Thomas R Ioerger; Takushi Kaneko; James C Sacchettini; Mariangela Biava; Tanya Parish; José M Argüello; Magnus Steigedal; Eric J Rubin
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Antibacterial activities of iron chelators against common nosocomial pathogens.

Authors:  Mitchell G Thompson; Brendan W Corey; Yuanzheng Si; David W Craft; Daniel V Zurawski
Journal:  Antimicrob Agents Chemother       Date:  2012-07-30       Impact factor: 5.191

Review 3.  Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.

Authors:  Ruslan Cusnir; Cinzia Imberti; Robert C Hider; Philip J Blower; Michelle T Ma
Journal:  Int J Mol Sci       Date:  2017-01-08       Impact factor: 5.923

4.  Insights on the relationship between structure vs. toxicological activity of antibacterial rhodamine-labelled 3-hydroxy-4-pyridinone iron(III) chelators in HepG2 cells.

Authors:  Tânia Moniz; Diana Dias da Silva; Helena Carmo; Baltazar de Castro; Maria de Lourdes Bastos; Maria Rangel
Journal:  Interdiscip Toxicol       Date:  2019-10-18

Review 5.  Iron in intracellular infection: to provide or to deprive?

Authors:  Sandro Silva-Gomes; Sílvia Vale-Costa; Rui Appelberg; Maria S Gomes
Journal:  Front Cell Infect Microbiol       Date:  2013-12-09       Impact factor: 5.293

Review 6.  Tuning the Anti(myco)bacterial Activity of 3-Hydroxy-4-pyridinone Chelators through Fluorophores.

Authors:  Maria Rangel; Tânia Moniz; André M N Silva; Andreia Leite
Journal:  Pharmaceuticals (Basel)       Date:  2018-10-20

Review 7.  Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms.

Authors:  M Amélia Santos; Anna Irto; Péter Buglyó; Sílvia Chaves
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.